Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med Chin    2009, Vol. 3 Issue (2) : 119-129    https://doi.org/10.1007/s11684-009-0022-9
RESEARCH ARTICLE
Establishment and drug sensitivity evaluation of murine ascites hepatocarcinoma cell line with high lymphatic metastatic potential (Hca-P/L6)
Hongying ZHANG1,2, Jianwu TANG2, Wenting ZHU1,2, Chunxiu HU1, Guowang XU1()
1. Department of Pathology & Forensic Medicine, Dalian Medical University, Dalian 116044, China; 2. National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China
 Download: PDF(437 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

In order to provide a sensitive cell line model for investigating the mechanisms underlying the lymphatic metastasis of tumors and the effect of medicine against cells, a new murine ascites hepatocarcinoma cell line with high lymphatic metastatic potential (Hca-P/L6) was established and the effect of curcumin on biological behavior of Hca-P/L6 was observed. Murine ascites hepatocarcinoma cell strain with low lymphatic metastatic potential (Hca-P) was subcutaneously inoculated into the medioventral line of a mouse 615 and the first generation of metastatic tumor cells of inguinal lymph node (Hca-P/L1) was obtained. Then, Hca-P/L1 was screened by the route of mouse foot pad subcutaneously → lymph node → scale-up culture in vitro → mouse foot pad subcutaneously for five times consecutively. The sensitivity of two murine ascites hepatocarcinoma cell lines (Hca-P and Hca-P/L6) and two anchorage-dependent human hepatocarcinoma cell lines (SMC7721 and HepG2) to curcumin were studied by use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after these cells had been pretreated by curcumin at the concentration of 15-240 μmol/L for 48 h. After pretreatment by curcumin at the maximum non-cytotoxic dose of 15 μmol/L in vitro, the effect of curcumin against cell proliferation of Hca-P and Hca-P/L6 was observed by inverted microscope, cell growth curve and cell population doubling time; the effects of curcumin on cell cycles of Hca-P/L6 and Hca-P were studied by flow cytometry (FCM). The results showed Hca-P/L6 spreading to the lymph nodes at multiple sites in mice was screened from Hca-P. The lymph node metastatic rate was 100%. Curcumin had significant growth inhibiting effect on both murine ascites and human hepatocarcinoma cell lines in a dose-dependent manner (P<0. 05). At concentrations of 30-120 μmol/L, curcumin had more inhibition on murine ascites hepatocarcinoma cell lines than on human anchorage-dependent hepatocarcinoma cell lines. At concentrations of 60-240 μmol/L, curcumin had more inhibition on Hca-P/L6 with (the 50% inhibitory concentration) IC50 of 51.48 μmol/L than on Hca-P with IC50 of 90.87 μmol/L. After pretreatment by curcumin at the maximum non-cytotoxic dose of 15 mol/L for 7 days, the proliferations of Hca-P/L6 and Hca-P were inhibited (P<0.05) in a time-dependent manner (P<0.01) and the population doubling time of Hca-P/L6 and Hca-P was prolonged (P<0.01), and curcumin had more inhibition on Hca-P/L6 than on Hca-P (P<0.05). After pretreatment by 15 μmol/L curcumin for 48 h, the morphous of Hca-P/L6 was influenced more seriously than that of Hca-P and the cell cycle was redistributed with Hca-P/L6 being blocked in the S phase and Hca-P in the S and G2/M phases. Hca-P/L6 was validated to be more sensitive to curcumin than Hca-P. Hca-P/L6 is a novel sensitive cell line model for investigating the mechanisms underlying tumor lymphatic metastasis and the effect of the medicine against cells.

Keywords murine ascites hepatocarcinoma cell line      metastasis      curcumin      drug sensitivity     
Corresponding Author(s): XU Guowang,Email:xugw@dicp.ac.cn   
Issue Date: 05 June 2009
 Cite this article:   
Hongying ZHANG,Jianwu TANG,Wenting ZHU, et al. Establishment and drug sensitivity evaluation of murine ascites hepatocarcinoma cell line with high lymphatic metastatic potential (Hca-P/L6)[J]. Front Med Chin, 2009, 3(2): 119-129.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0022-9
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I2/119
Fig.1  Histology of transplanted tumor of medioventral line of mouse 615 inoculated by Hca-P. Tumor cells were poorly differentiated, large and multilateral in shape and varied in size with several multinucleate giant cells. Local necrosis of tumor cells was obvious.
Fig.2  Histology of the metastatic tumor of inguinal node in mouse 615 inoculated by Hca-P. Normal structure of lymph node was partially preserved and large multilateral tumor cells were distributed in lamellar areas and varied in size.
Fig.3  Hca-P/L cells cultured in medium (×100). Tumor cells grew in suspension in large round shapes and had clear cytoplasm. Some of them were in clusters and a few large cells were in the state of differentiation and proliferation.
Fig.4  Hca-P cells cultured in medium (×100). Tumor cells grew in suspension in large round shape and had clear cytoplasm. A few were in clusters and few large cells were in the state of differentiation and proliferation.
cell linesinoculated mice (n)mice withlymphnodemetastas-is (n)lymph node metastasis rate/ %
popliteal (A)inguinal (B)axillary (C)celiac (D)renal hilar (E)
Hca-P2044/202/10000
Hca-P/L6202016/8014/7015/755/252/10
Tab.1  Lymph node spread of Hca-P and Hca-P/L in mouse 615
Fig.5  Relationship of the tumor close to the kidney with the adrenal gland in the first mouse. The tumor was adjacent and not invasive to the adrenal gland. The adrenal gland capsule was intact.
Fig.6  Histology of the tumor close to the kidney in the second mouse. There was lymphatic tissue in the tumor close to the kidney. The tumor cells were large, undifferentiated, and multilateral in shape and varied in size.
curcumin /μmol·L-1Hca-P/L6Hca-PSMC7721HepG2
0 (control )0.91±0.0690.654±0.0170.252±0.0020.404±0.007
150.865±0.040.642±0.0210.241±0.494
300.651±0.008**0.386±0.019**0.227±0.321**0.402±0.023
600.315±0.025**0.297±0.027**0.151±0.021*0.264±0.016**
1200.214±0.015**0.263±0.014**0.146±0.033**0.172±0.024*
2400.193±0.017**0.264±0.016**0.082±0.001**0.195±0.026**
Tab.2  Values of curcumin on Hca-P/L, Hca-P, SMC7721 and HepG
Fig.7  Inhibition of curcumin on Hca-P/L, Hca-P, SMC7721 and HepG (=9). Abbreviations are the same as in Table 2.
Fig.8  Effect of curcumin on cell growth curves of Hca-P/L and Hca-P (=18)
groupscurcumin/μmol·L-1population doubling time /h
Hca-P/L6Hca-P
control020.43±4.16**30.20±8.04
test1545.29±0.53**43.03±0.43**
Tab.3  Effect of curcumin on the population doubling times of Hca-P/L and Hca-P
Fig.9  Effect of curcumin on cell cycle distribution of Hca-P/L and Hca-P treated with curcumin for 48 h detected by flow cytometry. (a) Hca-P/L control croup; (b) Hca-P/L treated by curcumin group, cells were blocked in S phase; (c) Hca-P control group; (d) Hca-P treated by curcumin group, cells were blocked in S and G/M phases.
groupscurcumin /μmol·L-1cell cycle distribution/%
G1/G0SG2/M
Hca-P/L6 control020.1067.5812.31
Hca-P/L6 test1512.52*87.48*0*
Hca-P control034.4865.520
Hca-P test 1524.96#68.61#6.43#
Tab.4  Comparison of cell cycle distributions of Hca-P/L and Hca-P after treatment with curcumin for 48 h
1 Zhang X, Qi L W, Yi L, Li P, Wen X D, Yu Q T. Screening and identification of potential bioactive components in a combined prescription of Danggui Buxue decoction using cell extraction coupled with high performance liquid chromatography. Biomed Chromatogr , 2008, 22(2): 157-163
doi: 10.1002/bmc.910
2 Dantzig A H, Duckworth D C, Tabas L B. Transport mechanisms responsible for the absorption of loracarbef, cefixime and cefuroxime axetil into human intestinal Caco-2 cells. Biochem Biophys Acta , 1994, 1191(1): 7-13
doi: 10.1016/0005-2736(94)90226-7
3 Hidalgo I J, Raub T J, Borchardt R T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology , 1989, 96(3): 736-749
4 Meunier V, Bourrie M, Berger Y. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol , 1995, 11(3,4): 187-194
5 Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun , 1991, 175(3): 880-885
doi: 10.1016/0006-291X(91)91647-U
6 Ling M Y, Liu X F, Guan S Q, Yang, Long X, Zheng H Z, Gu S Z, Yu Q N. The screening and characters of cell clone with different metastatic ability. Dalian Yi Ke Da Xue Xue Bao , 1990, 1: 1-7 (in Chinese)
7 Liu M, Zhu J, Yang P M, Zhang J N. The expression of L-selectin in mouse liver tumor cell HCa-F and HCa-P and the potential relationship with metastasis. Jie Pou Xue Jin Zhan , 2003, 2: 100-104 (in Chinese)
8 Guo L Y, Shi G X, Gao Z H, Shen J, Xing R, Qian Z C. Response to hepatocarcinoma Hca-F of mice immunized with heat shock protein 70 from elemene combo tumor cell vaccine. Cell Mol Immunol , 2006, 4: 291-295
9 Sun C R, Tang J W, Sun M Z, Liu S Q, Zang H Y, Wang B, Song B, Zhang Y N, Zhang Z Q, Zhao Z Y. Identification lymphatic metastasis-associated proteins in mouse hepatocarcinoma cell Lines using quantitative proteomics technique. Sheng Wu Hua Xue Yu Wu Li Jin Zhan , 2007, 8: 856-864 (in Chinese)
10 Xie C S, Gao W C, Chen P Fg, Wu L C. The effect of Bcl-2 and bax of Chinese medicine ATU-I on 615 mice with HCa-F liver carcinomas. Zhong Hua Zhong Yi Yao Xue Kan , 2007, 1: 2327-2329 (in Chinese)
11 Fidler I L. Tumor heterogeneity and biology of cancer invasion and metastasis. Cancer Res , 1978, 38(9): 2651-2660
doi: 10.1016/S0065-230X(08)60648-X
12 Chen S, Ling M Y, Liu XF, Zhang C H. The stability of highly and lowly metastatic clonal cells from murine ascites hepatocarcinoma. Dalian Yi Ke Da Xue Xue Bao , 1992, 14: 32-37 (in Chinese)
13 Bai J, Wang B, Hou L, Li Y, Ling M Y, Lv S, Bai Y G. A fresh clone of small rat of ascites type liver cancer high lymph path transfer tumor individual plant HCa-F. Dalian Yi Ke Da Xue Xue Bao , 2003, 25(1): 65-66 (in Chinese)
14 Bromberg N, Justo G Z, Haun M, Duran N, Ferreira C V. Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases. J Enzyme Inhib Med Chem , 2005, 20: 449-454
doi: 10.1080/14756360500273052
15 Liu D F, Zhang B D, Sun Y L. The establishment of hepatic carcinoma cultured cell strain 80320 of mice. Ai Zheng , 1984, 3(3): 186-188, 230 (in Chinese)
16 Ling M Y, Zhang C, Gao W S, Zhu F C. Establishment of experimental lymphatic metastasis model of transplanting murine ascites hepatocarcinoma (H(22)). Dalian Yi Ke Da Xue Xue Bao , 1983, 2: 9-13 (in Chinese)
17 Lu W D, Yang J. Observation of the growth methods and general biological characteristics of murine ascites hepatocarcinoma (Hca). Zhong Guo Zhong Liu Lin Chuang , 1979, 3: 188-192 (in Chinese)
18 Ling M Y, Wang M Y, Zhang C, Liu X F. An observation on the morphology and metastatic potential to the ascites hepatomas (H(22)) in mice. Dalian Yi Ke Da Xue Xue Bao , 1987, 1: 27-32 (in Chinese)
19 Shao Z M, Shen Z Z, Liu C H, Sartippour M R, Go V L, Heber D, Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer , 2002, 98(2): 234-240
doi: 10.1002/ijc.10183
20 Menon L G, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett , 1995, 55(1-2): 221-225
doi: 10.1016/0304-3835(95)03887-3
21 Kuttan R, Bhanumathy P, Nirmala K, George M C. Potential anticancer activity of turmeric (Curcuma longa). J Cancer Lett , 1985, 29(2): 197-202
doi: 10.1016/0304-3835(85)90159-4
22 Khafif A, Schantz S P, Chou T C, Edelstein D, Sacks P G. Quantitation of chemopreventive synergism between epigallocatechin-3-gallate and Curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis , 1998, 19(3): 419-424
doi: 10.1093/carcin/19.3.419
[1] Yun Zhang, Robert A. Weinberg. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities[J]. Front. Med., 2018, 12(4): 361-373.
[2] Bo Zhou, Hongbin Xu, Meng Xia, Chaoyang Sun, Na Li, Ensong Guo, Lili Guo, Wanying Shan, Hao Lu, Yifan Wu, Yuan Li, Degui Yang, Danhui Weng, Li Meng, Junbo Hu, Ding Ma, Gang Chen, Kezhen Li. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer[J]. Front. Med., 2017, 11(2): 214-222.
[3] Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes[J]. Front. Med., 2016, 10(4): 444-450.
[4] Chunxiao Li,Haijuan Wang,Feng Lin,Hui Li,Tao Wen,Haili Qian,Qimin Zhan. Bioinformatic exploration of MTA1-regulated gene networks in colon cancer[J]. Front. Med., 2016, 10(2): 178-182.
[5] Jiangnan Liu,Bin Yi,Zhe Zhang,Yi Cao. CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes[J]. Front. Med., 2016, 10(2): 204-211.
[6] Felice Ho-Ching Tsang,Sandy Leung-Kuen Au,Lai Wei,Dorothy Ngo-Yin Fan,Joyce Man-Fong Lee,Carmen Chak-Lui Wong,Irene Oi-Lin Ng,Chun-Ming Wong. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility[J]. Front. Med., 2015, 9(3): 331-343.
[7] Lunxiu Qin. Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies[J]. Front Med, 2014, 8(1): 24-32.
[8] Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang. Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer[J]. Front Med, 2014, 8(1): 106-112.
[9] Carmen Chak-Lui Wong, Alan Ka-Lun Kai, Irene Oi-Lin Ng. The impact of hypoxia in hepatocellular carcinoma metastasis[J]. Front Med, 2014, 8(1): 33-41.
[10] Dong KUANG, Guo-Ping WANG, . Hilar cholangiocarcinoma: Pathology and tumor biology[J]. Front. Med., 2010, 4(4): 371-377.
[11] Ling XU MM, Feng WANG MM, Xuan-Fu XU MD, Wen-Hui MO BM, Rong WAN MD, Chuan-Yong GUO MD, Xing-Peng WANG MD, . Data mining of microarray for differentially expressed genes in liver metastasis from gastric cancer[J]. Front. Med., 2010, 4(2): 247-253.
[12] Liu LIU MD, PhD, Yaogui NING MM, Chen CHEN MD, Daowen WANG MD, PhD, . Effect of atorvastatin on tumor growth and metastasis in a breast cancer cell xenograft model and its mechanism[J]. Front. Med., 2009, 3(4): 443-446.
[13] Yang YU, Jibin LIU, Lixue YIN. Application progress of lymphography in oncology[J]. Front Med Chin, 2009, 3(1): 13-19.
[14] QIN Lunxiu, TANG Zhaoyou, GUAN Xinyuan, YE Qinghai, JIA Huliang, REN Ning. The predictive value of chromosome 8p deletion for metastasis of hepatocellular carcinoma: a summary of works in 10 years[J]. Front. Med., 2008, 2(3): 211-215.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed